FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309522653> ?p ?o ?g. }

• W4309522653 endingPage "256" @default.
• W4309522653 startingPage "252" @default.
• W4309522653 abstract "To evaluate the genotypic and ceftazidime/avibactam-susceptibility profiles amongst ceftolozane/tazobactam-non-susceptible (NS), MBL-negative Pseudomonas aeruginosa in a global surveillance programme.Isolates were collected as part of the ERACE-PA Global Surveillance programme. Carbapenem-resistant P. aeruginosa deemed clinically relevant by the submitting laboratories were included. Broth microdilution MICs were conducted per CLSI standards to ceftolozane/tazobactam, ceftazidime/avibactam, ceftazidime and cefepime. Genotypic carbapenemases were detected using CarbaR and CarbaR NxG (research use only). Isolates negative for carbapenemases by PCR were assessed via WGS. Isolates were included in the analysis if they were ceftolozane/tazobactam-NS and lacked detection of known MBLs.Of the 807 isolates collected in the ERACE-PA programme, 126 (16%) were ceftolozane/tazobactam-NS and lacked MBLs. Cross-resistance to ceftazidime and cefepime was common, with only 5% and 16% testing susceptible, respectively. Ceftazidime/avibactam retained in vitro activity, with 65% of isolates testing susceptible. GES was the most common enzymology, detected in 57 (45%) isolates, and 89% remained susceptible to ceftazidime/avibactam. Seven isolates harboured KPC and all tested susceptible to ceftazidime/avibactam. In the remaining 62 isolates, WGS revealed various ESBLs or OXA β-lactamases. While 39% remained susceptible to ceftazidime/avibactam, marked variability was observed among the diverse resistance mechanisms.Ceftazidime/avibactam remained active in vitro against the majority of ceftolozane/tazobactam-NS, MBL-negative P. aeruginosa. Ceftazidime/avibactam was highly active against isolates harbouring GES and KPC β-lactamases. These data highlight the potential clinical utility of genotypic profiling as well as the need to test multiple novel agents when carbapenem-resistant P. aeruginosa are encountered." @default.
• W4309522653 created "2022-11-28" @default.
• W4309522653 creator A5001141136 @default.
• W4309522653 creator A5009642231 @default.
• W4309522653 creator A5010487406 @default.
• W4309522653 creator A5012938560 @default.
• W4309522653 creator A5015013063 @default.
• W4309522653 creator A5022980048 @default.
• W4309522653 creator A5023157477 @default.
• W4309522653 creator A5023479710 @default.
• W4309522653 creator A5025903975 @default.
• W4309522653 creator A5026024562 @default.
• W4309522653 creator A5028200056 @default.
• W4309522653 creator A5029272832 @default.
• W4309522653 creator A5031044365 @default.
• W4309522653 creator A5032746098 @default.
• W4309522653 creator A5036220332 @default.
• W4309522653 creator A5037040389 @default.
• W4309522653 creator A5038660145 @default.
• W4309522653 creator A5044157939 @default.
• W4309522653 creator A5049685699 @default.
• W4309522653 creator A5050014117 @default.
• W4309522653 creator A5051515820 @default.
• W4309522653 creator A5053449231 @default.
• W4309522653 creator A5054640183 @default.
• W4309522653 creator A5057123569 @default.
• W4309522653 creator A5058683198 @default.
• W4309522653 creator A5058693980 @default.
• W4309522653 creator A5058918536 @default.
• W4309522653 creator A5059991849 @default.
• W4309522653 creator A5062302144 @default.
• W4309522653 creator A5062566457 @default.
• W4309522653 creator A5067530676 @default.
• W4309522653 creator A5069933550 @default.
• W4309522653 creator A5070942163 @default.
• W4309522653 creator A5071676972 @default.
• W4309522653 creator A5072442510 @default.
• W4309522653 creator A5072455751 @default.
• W4309522653 creator A5072728300 @default.
• W4309522653 creator A5075014516 @default.
• W4309522653 creator A5075932147 @default.
• W4309522653 creator A5076324401 @default.
• W4309522653 creator A5077782292 @default.
• W4309522653 creator A5083971720 @default.
• W4309522653 creator A5088741251 @default.
• W4309522653 creator A5091119758 @default.
• W4309522653 creator A5091132383 @default.
• W4309522653 creator A5091205344 @default.
• W4309522653 creator A5091643420 @default.
• W4309522653 date "2022-11-22" @default.
• W4309522653 modified "2023-10-18" @default.
• W4309522653 title "Phenotypic and genotypic profile of ceftolozane/tazobactam-non-susceptible, carbapenem-resistant <i>Pseudomonas aeruginosa</i>" @default.
• W4309522653 cites W2091090665 @default.
• W4309522653 cites W2293828825 @default.
• W4309522653 cites W2739559315 @default.
• W4309522653 cites W2765514197 @default.
• W4309522653 cites W2941231904 @default.
• W4309522653 cites W3014918727 @default.
• W4309522653 cites W3094338265 @default.
• W4309522653 cites W3094445652 @default.
• W4309522653 cites W3117305349 @default.
• W4309522653 cites W3121196851 @default.
• W4309522653 cites W3162905453 @default.
• W4309522653 cites W3170817121 @default.
• W4309522653 cites W3184556518 @default.
• W4309522653 cites W4206571317 @default.
• W4309522653 cites W4214922586 @default.
• W4309522653 cites W4225275122 @default.
• W4309522653 cites W4285733344 @default.
• W4309522653 doi "https://doi.org/10.1093/jac/dkac385" @default.
• W4309522653 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36411249" @default.
• W4309522653 hasPublicationYear "2022" @default.
• W4309522653 type Work @default.
• W4309522653 citedByCount "3" @default.
• W4309522653 countsByYear W43095226532023 @default.
• W4309522653 crossrefType "journal-article" @default.
• W4309522653 hasAuthorship W4309522653A5001141136 @default.
• W4309522653 hasAuthorship W4309522653A5009642231 @default.
• W4309522653 hasAuthorship W4309522653A5010487406 @default.
• W4309522653 hasAuthorship W4309522653A5012938560 @default.
• W4309522653 hasAuthorship W4309522653A5015013063 @default.
• W4309522653 hasAuthorship W4309522653A5022980048 @default.
• W4309522653 hasAuthorship W4309522653A5023157477 @default.
• W4309522653 hasAuthorship W4309522653A5023479710 @default.
• W4309522653 hasAuthorship W4309522653A5025903975 @default.
• W4309522653 hasAuthorship W4309522653A5026024562 @default.
• W4309522653 hasAuthorship W4309522653A5028200056 @default.
• W4309522653 hasAuthorship W4309522653A5029272832 @default.
• W4309522653 hasAuthorship W4309522653A5031044365 @default.
• W4309522653 hasAuthorship W4309522653A5032746098 @default.
• W4309522653 hasAuthorship W4309522653A5036220332 @default.
• W4309522653 hasAuthorship W4309522653A5037040389 @default.
• W4309522653 hasAuthorship W4309522653A5038660145 @default.
• W4309522653 hasAuthorship W4309522653A5044157939 @default.
• W4309522653 hasAuthorship W4309522653A5049685699 @default.
• W4309522653 hasAuthorship W4309522653A5050014117 @default.
• W4309522653 hasAuthorship W4309522653A5051515820 @default.
• W4309522653 hasAuthorship W4309522653A5053449231 @default.

• next